BLUEBIRD STRATEGIES

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 6, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Issues related to drug pricing, FDA drug regulations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.